T. Rowe Price Innovation Leaders ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: --
資產淨值: 25.86
成立日期: 28/01/2026
 
分析
市值分佈:
90.45%
大市值
2.80%
中市值
0.15%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:09) 總持有投資項目: 222  
0%
 
100%
     10大 (32.15%)
代號 名稱 佔比% 持有日期
TMXXFTMX Group Ltd.0.0729/04/2026
IBNICICI Bank Limited0.0629/04/2026
RAPPRapport Therapeutics Inc.0.0629/04/2026
PVLAPalvella Therapeutics Inc0.0629/04/2026
CRBGCorebridge Financial0.0629/04/2026
ZSZscaler0.0629/04/2026
WVEWave Life Sciences Ltd0.0629/04/2026
WALWestern Alliance Bancorporation0.0629/04/2026
KMTSKestra Medical Technologies, Ltd.0.0629/04/2026
ORICOric Pharmaceuticals0.0529/04/2026
RLAYRelay Therapeutics0.0529/04/2026
CLDXCelldex Therapeutics0.0529/04/2026
MBFJFMitsubishi UFJ Financial Group, Inc.0.0529/04/2026
MLTXMoonLake Immunotherapeutics0.0529/04/2026
STOKStoke Therapeutics0.0529/04/2026
VRRMVerra Mobility Corp0.0529/04/2026
BCAXBicara Therapeutics Inc.0.0529/04/2026
FITBFifth Third Bancorp0.0529/04/2026
ERASErasca0.0529/04/2026
CCCCCC Intelligent Solutions Holdings Inc.0.0429/04/2026
  1    2    3    4    5    6    7    8    9    10   11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.